Doug Elwood, MD, MBA
About Doug Elwood, MD, MBA
Doug Elwood, MD, MBA, is the Co-Founder and CEO of EnSage Health and serves as an Assistant Clinical Professor at NYU Langone Medical Center. He has over 15 years of experience in innovative care delivery models and digital health initiatives.
Current Role at EnSage Health
Doug Elwood, MD, MBA, is the Co-Founder and CEO of EnSage Health, a company based in New York, United States. Since 2022, he has led the organization in developing AI-powered dementia care solutions. His leadership leverages over 15 years of experience in innovative care delivery models, driving EnSage Health to focus on technologically advanced healthcare solutions.
Board Technology Committee Membership
Since 2022, Doug Elwood has served on Project Sunshine's Board Technology Committee in New York, United States. In this role, he contributes his expertise in digital health initiatives, emphasizing patient engagement and the implementation of cutting-edge technology to improve healthcare outcomes.
Experience at PWNHealth
Doug Elwood was the Chief Medical Officer at PWNHealth from 2015 to 2022, based in the Greater New York City Area. Over these seven years, he focused on telehealth and clinician management, playing a critical role in advancing health and wellness within the organization. His contributions significantly shaped PWNHealth’s approach to integrating digital health into patient care.
Background in Global Health and Wellness
Between 2014 and 2015, Doug Elwood worked at Porter Novelli as the Global Health and Wellness Senior Vice President and Medical Advisor. His one-year tenure in the Greater New York City Area involved steering global health strategies and providing medical advice to enhance the company’s wellness initiatives.
Academic Background and Medical Education
Doug Elwood completed his MD/MBA at Jefferson Medical College, where he studied Medicine and Business from 1999 to 2005. Prior to that, he obtained a BA in English Literature from Amherst College, studying from 1994 to 1998. His diverse academic background supports his multifaceted approach to healthcare innovation and leadership.